Belite Bio Adr Stock Market Value
| BLTE Stock | USD 63.26 4.18 6.20% |
| Symbol | Belite |
Belite Bio ADR Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Belite Bio. If investors know Belite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Belite Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.10) | Return On Assets (0.26) | Return On Equity (0.40) |
The market value of Belite Bio ADR is measured differently than its book value, which is the value of Belite that is recorded on the company's balance sheet. Investors also form their own opinion of Belite Bio's value that differs from its market value or its book value, called intrinsic value, which is Belite Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Belite Bio's market value can be influenced by many factors that don't directly affect Belite Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Belite Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Belite Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Belite Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Belite Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Belite Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Belite Bio.
| 09/02/2024 |
| 12/01/2024 |
If you would invest 0.00 in Belite Bio on September 2, 2024 and sell it all today you would earn a total of 0.00 from holding Belite Bio ADR or generate 0.0% return on investment in Belite Bio over 90 days. Belite Bio is related to or competes with Anebulo Pharmaceuticals, Mineralys Therapeutics,, AN2 Therapeutics, Aerovate Therapeutics, Adagene, Larimar Therapeutics, and Immuneering Corp. Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of... More
Belite Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Belite Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Belite Bio ADR upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.42 | |||
| Information Ratio | 0.0824 | |||
| Maximum Drawdown | 30.69 | |||
| Value At Risk | (6.09) | |||
| Potential Upside | 5.93 |
Belite Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Belite Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Belite Bio's standard deviation. In reality, there are many statistical measures that can use Belite Bio historical prices to predict the future Belite Bio's volatility.| Risk Adjusted Performance | 0.0968 | |||
| Jensen Alpha | 0.3795 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0765 | |||
| Treynor Ratio | 0.6895 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Belite Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Belite Bio ADR Backtested Returns
Belite Bio appears to be very steady, given 3 months investment horizon. Belite Bio ADR secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. By analyzing Belite Bio's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please makes use of Belite Bio's Mean Deviation of 2.3, risk adjusted performance of 0.0968, and Downside Deviation of 4.42 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Belite Bio holds a performance score of 9. The firm shows a Beta (market volatility) of 0.68, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Belite Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Belite Bio is expected to be smaller as well. Please check Belite Bio's total risk alpha, expected short fall, market facilitation index, as well as the relationship between the value at risk and daily balance of power , to make a quick decision on whether Belite Bio's price patterns will revert.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Belite Bio ADR has insignificant reverse predictability. Overlapping area represents the amount of predictability between Belite Bio time series from 2nd of September 2024 to 17th of October 2024 and 17th of October 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Belite Bio ADR price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Belite Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 82.88 |
Belite Bio ADR lagged returns against current returns
Autocorrelation, which is Belite Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Belite Bio's stock expected returns. We can calculate the autocorrelation of Belite Bio returns to help us make a trade decision. For example, suppose you find that Belite Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Belite Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Belite Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Belite Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Belite Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Belite Bio Lagged Returns
When evaluating Belite Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Belite Bio stock have on its future price. Belite Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Belite Bio autocorrelation shows the relationship between Belite Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Belite Bio ADR.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Belite Bio ADR is a strong investment it is important to analyze Belite Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Belite Bio's future performance. For an informed investment choice regarding Belite Stock, refer to the following important reports:Check out Belite Bio Correlation, Belite Bio Volatility and Belite Bio Alpha and Beta module to complement your research on Belite Bio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Belite Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.